Relative change in hs-cTnT (hs-cTnTx+Δx/hs-cTnTx (95% CI in parentheses) by unit change (Δx)) of the covariables
| Hs-cTnTx+Δx/hs-cTnTx | ||||
|---|---|---|---|---|
| Covariate | Change of covariable (Δx) | Total cohort | Exacerbation | Stable state |
| Gender | Female versus male | 0.74 (0.54 to 1.02) | 0.85 (0.53 to 1.35) | 0.69 (0.44 to 1.05) |
| Age | Quartile | 1.05 (0.92 to 1.20) | 1.03 (0.83 to 1.28) | 1.03 (0.87 to 1.21) |
| LTOT | Yes versus no | 1.94 (1.27 to 2.98) | 1.20 (0.62 to 2.31) | 2.66 (1.57 to 4.50) |
| ECG: q-wave | Yes versus no | 2.00 (1.17 to 3.44) | NA | 1.89 (1.08 to 3.28) |
| ECG: LVH | Yes versus no | 2.33 (1.04 to 5.20) | 0.89 (0.20 to 4.06) | 3.36 (1.32 to 8.56) |
| FEV1 | Quartile | 0.81 (0.69 to 0.96) | 1.03 (0.78 to 1.32) | 0.73 (0.60 to 0.89) |
| Leucocytes | Quartile | 1.30 (1.14 to 1.50) | 1.06 (0.83 to 1.36) | 1.41 (1.20 to 1.68) |
| Creatinine | Quartile | 1.15 (1.00 to 1.33) | 0.92 (0.74 to 1.15) | 1.21 (1.01 to 1.47) |
| AECOPD | Yes versus no | 4.26 (3.02 to 6.00) | – | – |
AECOPD, acute exacerbation of chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 s; LTOT, long-term oxygen treatment; LVH, left ventricular hypertrophy; NA, not available (only one patient).